ArcticZymes Technologies ASA (LON:0DRV)

Market Cap	74.96M +15.1%
Revenue (ttm)	8.71M +9.3%
Net Income	728.28K +16.7%
EPS	0.01 +14.3%
Shares Out	n/a
PE Ratio	102.93
Forward PE	45.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220
Average Volume	793
Open	19.00
Previous Close	n/a
Day's Range	19.00 - 19.00
52-Week Range	14.50 - 31.00
Beta	0.39
RSI	34.29
Earnings Date	Apr 30, 2026

About LON:0DRV

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 53
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DRV

Financial Performance

In 2025, LON:0DRV's revenue was 118.21 million, an increase of 9.34% compared to the previous year's 108.11 million. Earnings were 9.88 million, an increase of 16.66%.

Financial numbers in NOK